Testing effectiveness (Phase 2)Study completedNCT00600119
What this trial is testing
A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)
Who this might be right for
Opioid Induced Constipation (OIC)
AstraZeneca 207